Sam Hall
Direktor/Vorstandsmitglied bei Burke Neurological Institute
Ursprung des Netzwerks ersten Grades von Sam Hall
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Cambridge
246
| College/University | Other Consumer Services | 246 |
Citigroup Asset Management
73
| Extinct | Investment Managers | 73 |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.
22
| Private Company | Investment Managers | 22 |
| Public Company | Biotechnology | 17 | |
Accelerate Long Island (Venture Capital)
 Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York.
14
| Private Company | Investment Managers | 14 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.
9
| Subsidiary | Biotechnology | 9 |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA.
3
| Private Company | Biotechnology | 3 |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA.
2
| Holding Company | Biotechnology | 2 |
Chinook Therapeutics U.S., Inc.
 Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA.
1
| Subsidiary | Information Technology Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sam Hall
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Private Equity Investor Consultant / Advisor | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rochester Christian University | College/University | Doctorate Degree Undergraduate Degree | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Human Resources Officer General Counsel | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer General Counsel | |
| SHIRE | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree | |
BII Group Ltd.
 BII Group Ltd. Investment ManagersFinance BII Group Ltd. (BII Group) is a private equity/venture capital, a subsidiary of Government of United Kingdom was founded by James Murray Grant in 1948. The firm is headquartered in London with offices in Bengaluru, Mumbai, Nairobi, Pakistan, Sandton, and Bangladesh. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
ECI Partners LLP
 ECI Partners LLP Investment ManagersFinance ECI Partners LLP (ECI Partners) is a private equity founded in 1976. The firm is headquartered in London, the United Kingdom with an additional offices in Manchester and New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Leeds | College/University | Graduate Degree Doctorate Degree | |
Inflexion Private Equity Partners LLP
 Inflexion Private Equity Partners LLP Investment ManagersFinance Inflexion Private Equity Partners LLP (Inflexion Private Equity Partners) is a private equity firm founded in 1999 by John Frederick Hartz and Simon Eric Hugh Turner. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Brandeis University | College/University | Graduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University | College/University | Graduate Degree Private Equity Investor | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University College London | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Tokyo | College/University | Graduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Medical Specialties | Chairman Chief Executive Officer | |
| BRAEBURN INC. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Private Equity Investor | |
Gala Therapeutics, Inc.
 Gala Therapeutics, Inc. BiotechnologyHealth Technology Gala Therapeutics, Inc. engages in biotech and pharma products. The company was founded in October 2015 by Jonathan Reuben Waldstreicher and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Founder | |
Tusker Medical, Inc.
 Tusker Medical, Inc. Medical SpecialtiesHealth Technology Tusker Medical, Inc. engages in the development of medical devices for ear, nose, and throat treatments. It offers iontophoresis system and tube delivery system. The company is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| ENECHANGE LTD. | Internet Software/Services | Founder | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Accelerate Long Island, Inc.
 Accelerate Long Island, Inc. Finance/Rental/LeasingFinance Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY. | Finance/Rental/Leasing | Private Equity Investor Director/Board Member Director of Finance/CFO | |
SMAP Energy Ltd.
 SMAP Energy Ltd. Data Processing ServicesTechnology Services Part of Enechange Ltd., SMAP Energy Ltd. is a company based in London, UK. SMAP Energy originated from research at the University of Cambridge, where the team worked with academics, data scientists, and utility clients across the world to build and develop the next generation of data analytics tools. The British company seeks to transform the way energy providers and customers look at energy consumption by analyzing user behavior to derive insights that can make the energy sector more efficient. SMAP Energy's smart meter analytics platform helps utilities and other aggregators of energy consumption data to pull out the complex insights contained in the data. The company was founded in 2014 by Paul Monroe, Adnan Mortada, Yohei Kiguchi. Yohei Kiguchi has been the CEO since 2014. | Data Processing Services | Chief Executive Officer | |
Galaxy Medical, Inc.
 Galaxy Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Galaxy Medical, Inc. provides biotechnology services. The company is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Galvanize Therapeutics, Inc.
 Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
Galavant Therapeutics, Inc.
 Galavant Therapeutics, Inc. BiotechnologyHealth Technology Galavant Therapeutics, Inc. operates a biotechnology firm. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Nine Square Therapeutics, Inc.
 Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Initial Therapeutics Inc
 Initial Therapeutics Inc BiotechnologyHealth Technology Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Ascidian Therapeutics, Inc.
 Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Mount Sinai Innovation Partners
 Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Mount Sinai Innovation Partners is a private company that focuses on translating discoveries and inventions into healthcare products and services that benefit patients and society. The company is based in New York, NY. The company is responsible for evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. | Miscellaneous Commercial Services | President Consultant / Advisor | |
Nereid Therapeutics, Inc.
 Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Apertor Pharmaceuticals, Inc.
 Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member President | |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Replicate Bioscience, Inc.
 Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| Providence Strategic Growth LLP | Investment Managers | Private Equity Investor Private Equity Investor | |
| Japan Energy Capital / UK | Investment Managers | Private Equity Investor |
Statistik
International
| Vereinigte Staaten | 39 |
| Vereinigtes Königreich | 8 |
| Japan | 3 |
| Irland | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 14 |
| Finance | 8 |
| Commercial Services | 6 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 175 |
| Corporate Officer/Principal | 102 |
| Private Equity Investor | 89 |
| Undergraduate Degree | 86 |
| Graduate Degree | 58 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Seth Harrison | 43 |
| James Giallanza | 19 |
| Erik Lium | 17 |
| David Calone | 16 |
| Michael Ehlers | 15 |
| Anna Batarina | 15 |
| Julie Smith | 15 |
| Arthur Tzianabos | 15 |
| Edward Kaye | 13 |
| Rupert Vessey | 13 |
| Shamim Ruff | 12 |
| Behshad Sheldon | 12 |
| Noel Goddard | 11 |
| Jonathan Waldstreicher | 11 |
| Samuel David Harrison | 11 |